DATA I/O CORP DAIO Financial Statement Data


2025 Q2

Submissions

Field Row 1 Row 2
adsh 0001654954-25-005511 0001654954-25-003717
cik 351998 351998
name DATA I/O CORP DATA I/O CORP
sic 3825 3825
countryba US US
stprba WA WA
cityba REDMOND REDMOND
zipba 98052 98052
bas1 6645 185TH AVE NE, SUITE 100 6645 185TH AVE NE, SUITE 100
bas2
baph 4258676922 4258676922
countryma US US
stprma WA WA
cityma REDMOND REDMOND
zipma 98052 98052
mas1 6645 185TH AVE NE, SUITE 100 6645 185TH AVE NE, SUITE 100
mas2
countryinc US US
stprinc WA WA
ein 910864123 910864123
former
changed
afs 4-NON 4-NON
wksi 0 0
fye 1130 1130
form 10-Q 10-K
period 20250331 20241231
fy 2025 2024
fp Q1 FY
filed 20250513 20250401
accepted 2025-05-13 13:47:00.0 2025-03-31 20:36:00.0
prevrpt 0 0
detail 1 1
instance daio_10q_htm.xml daio_10k_htm.xml
nciks 1 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0001654954-25-005511 20250331 Operating Lease Liability 1906000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20241231 Accounts Receivable Net Current 3960000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20231231 Adjustments To Equipment Transferred To Cost Of Goods Sold -301000.0000 USD 4 0001654954-25-003717
0001654954-25-003717 20231231 Assets 7829000.0000 USD 0 us-gaap/2024 Income Tax Authority Name= China;
0001654954-25-003717 20231231 Assets 14606000.0000 USD 0 us-gaap/2024 Income Tax Authority Name= U S A;
0001654954-25-003717 20231231 Assets Current 24613000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20231231 Cost Of Goods And Services Sold 11878000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Deferred Revenue Current 1535000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20231231 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 680000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Income Tax Expense Benefit 386000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Increase Decrease In Accounts Payable And Accrued Liabilities 109000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Increase Decrease In Inventories -815000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Increase Decrease In Other Current Assets 48000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Interest Income Other 273000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Net Cash Provided By Used In Investing Activities -467000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Net Income Loss -3093000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Operating Expenses 15738000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Operating Income Loss -3038000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Operating Lease Liability 702000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20241231 Other Comprehensive Income Loss Net Of Tax -344000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Other Comprehensive Income Loss Net Of Tax -344000.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-003717 20231231 Proceeds From Issuance Of Common Stock -356000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Property Plant And Equipment Net 1359000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20241231 Research And Development Expense 6240000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Revenues 6237000.0000 USD 4 us-gaap/2024 Geographical= Europes;
0001654954-25-003717 20231231 Share Based Compensation 1190000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Shares Issued 9020819.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-003717 20241231 Stock Awards Issued Net Of Tax Withholding Amount -246000.0000 USD 4 0001654954-25-003717 Equity Components= Common Stock;
0001654954-25-003717 20221231 Stockholders Equity 19109000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20231231 Stockholders Equity 22731000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-003717 20241231 Stockholders Equity -5738000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-003717 20241231 Stock Issued During Period Value Employee Stock Purchase Plan 0.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-003717 20231231 Weighted Average Number Of Shares Outstanding Basic 8941000.0000 shares 4 us-gaap/2024
0001654954-25-005511 20250331 Accrued Income Taxes Current 39000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 0.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-005511 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-005511 20241231 Assets Current 21157000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20250331 Depreciation And Amortization 127000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20250331 Earnings Per Share Basic -0.0400 USD 1 us-gaap/2024
0001654954-25-005511 20240331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -766000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20250331 Income Taxes Paid Net 21000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20241231 Liabilities And Stockholders Equity 24970000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20250331 Liabilities Current 5001000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20240331 Net Income Loss -807000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-005511 20250331 Net Income Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-005511 20241231 Other Assets Noncurrent 2812000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20250331 Other Comprehensive Income Loss Net Of Tax 0.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-005511 20250331 Preferred Stock Shares Authorized 5000000.0000 shares 0 us-gaap/2024
0001654954-25-005511 20240331 Stockholders Equity 65000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-005511 20241231 Stockholders Equity 17626000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20241231 Stockholders Equity -111000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-005511 20250331 Stockholders Equity 15000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-005511 20250331 Accounts Payable Current 1342000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20241231 Accrued Compensation 1517000.0000 USD 0 0001654954-25-003717
0001654954-25-003717 20231231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 1190000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 976000.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-003717 20221231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 11510000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20241231 Earnings Per Share Basic -0.3400 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Increase Decrease In Deferred Revenue -267000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Increase Decrease In Other Noncurrent Liabilities -684000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Inventory Net 5875000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20241231 Liabilities Current 5072000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20241231 Net Cash Provided By Used In Operating Activities -995000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Net Income Loss 0.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-003717 20241231 Other Assets Current 659000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20231231 Other Comprehensive Income Loss Net Of Tax -110000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Other Comprehensive Income Loss Net Of Tax 0.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-003717 20241231 Preferred Stock Shares Authorized 200000.0000 shares 0 us-gaap/2024 Class Of Stock= Series A Preferred Stock;
0001654954-25-003717 20241231 Proceeds From Issuance Of Common Stock -232000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Stock Awards Issued Net Of Tax Withholding Amount 0.0000 USD 4 0001654954-25-003717 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-003717 20241231 Stock Awards Issued Net Of Tax Withholding Amount 0.0000 USD 4 0001654954-25-003717 Equity Components= Retained Earnings;
0001654954-25-003717 20241231 Stockholders Equity -111000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-003717 20241231 Stockholders Equity 23475000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-003717 20231231 Stock Issued During Period Shares Employee Stock Purchase Plans 3266.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-003717 20241231 Stock Issued During Period Value Employee Stock Purchase Plan 0.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-003717 20241231 Weighted Average Number Of Shares Outstanding Basic 9150000.0000 shares 4 us-gaap/2024
0001654954-25-005511 20250331 Revenues 1963000.0000 USD 1 us-gaap/2024 Product Or Service= Adapter Sales;
0001654954-25-005511 20241231 Accumulated Other Comprehensive Income Loss Net Of Tax -111000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20250331 Accumulated Other Comprehensive Income Loss Net Of Tax 15000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 281000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20250331 Common Stock Shares Authorized 30000000.0000 shares 0 us-gaap/2024
0001654954-25-005511 20241231 Deferred Revenue Current 1535000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20250331 Deferred Revenue Current 1460000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20240331 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents -169000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20250331 Income Tax Expense Benefit 21000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20240331 Increase Decrease In Deposit Other Assets -202000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20240331 Interest Income Other 80000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20250331 Issuance Of Stock Through Espp Amount 6000.0000 USD 1 0001654954-25-005511
0001654954-25-005511 20250331 Net Income Loss -382000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-005511 20250331 Operating Expenses 3565000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20250331 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 126000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20240331 Other Comprehensive Income Loss Net Of Tax -168000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-005511 20250331 Revenues 3317000.0000 USD 1 us-gaap/2024 Product Or Service= Equipment Sales;
0001654954-25-005511 20250331 Stock Awards Issued Net Of Tax Withholding Amount -3000.0000 USD 1 0001654954-25-005511 Equity Components= Common Stock;
0001654954-25-005511 20240331 Stockholders Equity -3452000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-005511 20241231 Stockholders Equity 23475000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-005511 20250331 Weighted Average Number Of Diluted Shares Outstanding 9238000.0000 shares 1 us-gaap/2024
0001654954-25-003717 20231231 Accounts Payable Current 1272000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20241231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 976000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Assets Current 21157000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20231231 Common Stock Shares Outstanding 9020819.0000 shares 0 us-gaap/2024
0001654954-25-003717 20231231 Earnings Per Share Diluted 0.0500 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Foreign Currency Transaction Gain Loss Before Tax 42000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Liabilities And Stockholders Equity 27401000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20231231 Net Income Loss 486000.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-003717 20231231 Nonoperating Income Expense 232000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Operating Income Loss -1216000.0000 USD 4 us-gaap/2024 Geographical= Americas;
0001654954-25-003717 20241231 Other Accrued Liabilities Current 1161000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20241231 Other Assets Noncurrent 2812000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20231231 Other Comprehensive Income Loss Net Of Tax 0.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-003717 20231231 Other Comprehensive Income Loss Net Of Tax 0.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-003717 20241231 Payments To Acquire Property Plant And Equipment 467000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Preferred Stock Shares Authorized 200000.0000 shares 0 us-gaap/2024 Class Of Stock= Series A Preferred Stock;
0001654954-25-003717 20241231 Preferred Stock Shares Authorized 5000000.0000 shares 0 us-gaap/2024
0001654954-25-003717 20241231 Revenues 21769000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Selling General And Administrative Expense 9214000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Stock Awards Issued Net Of Tax Withholding Amount 0.0000 USD 4 0001654954-25-003717 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-003717 20241231 Stockholders Equity 17626000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20231231 Stock Issued During Period Value Employee Stock Purchase Plan 14000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Stock Issued During Period Value Employee Stock Purchase Plan 14000.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-003717 20231231 Weighted Average Number Of Diluted Shares Outstanding 9073000.0000 shares 4 us-gaap/2024
0001654954-25-005511 20241231 Accounts Receivable Net Current 3960000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20250331 Accounts Receivable Net Current 3865000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20240331 Adjustments To Equipment Transferred To Cost Of Goods Sold -251000.0000 USD 1 0001654954-25-005511
0001654954-25-005511 20250331 Adjustments To Equipment Transferred To Cost Of Goods Sold -9000.0000 USD 1 0001654954-25-005511
0001654954-25-005511 20241231 Assets 24970000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20250331 Assets Current 21015000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 10485000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20250331 Cost Of Goods And Services Sold 2988000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20240331 Foreign Currency Transaction Gain Loss Before Tax 14000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20240331 Income Taxes Paid Net 109000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20240331 Increase Decrease In Accounts Payable And Accrued Liabilities -649000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20250331 Increase Decrease In Inventories -409000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20250331 Issuance Of Stock Through Espp Amount 6000.0000 USD 1 0001654954-25-005511 Equity Components= Common Stock;
0001654954-25-005511 20240331 Net Cash Provided By Used In Financing Activities 7000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20250331 Net Cash Provided By Used In Financing Activities 2000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20240331 Net Cash Provided By Used In Operating Activities -41000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20240331 Net Income Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-005511 20240331 Other Comprehensive Income Loss Net Of Tax -168000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20250331 Other Comprehensive Income Loss Net Of Tax 126000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-005511 20250331 Preferred Stock Shares Authorized 200000.0000 shares 0 us-gaap/2024 Class Of Stock= Series A Preferred Stock;
0001654954-25-005511 20250331 Property Plant And Equipment Net 921000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20250331 Revenues 896000.0000 USD 1 us-gaap/2024 Product Or Service= Software And Maintenance Sales;
0001654954-25-005511 20250331 Share Based Compensation 174000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20250331 Stock Awards Issued Net Of Tax Withholding Amount 0.0000 USD 1 0001654954-25-005511 Equity Components= Retained Earnings;
0001654954-25-005511 20250331 Stock Awards Issued Net Of Tax Withholding Shares 1759.0000 shares 1 0001654954-25-005511 Equity Components= Common Stock;
0001654954-25-005511 20231231 Stockholders Equity -2645000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-005511 20240331 Stockholders Equity 23019000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-005511 20241231 Stockholders Equity -5738000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-005511 20250331 Stockholders Equity 17547000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20250331 Stockholders Equity -6120000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-003717 20231231 Accrued Income Taxes Current 113000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20231231 Accounts Receivable Net Current 5707000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20231231 Accrued Compensation 2003000.0000 USD 0 0001654954-25-003717
0001654954-25-003717 20241231 Accumulated Other Comprehensive Income Loss Net Of Tax -111000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20241231 Adjustments To Equipment Transferred To Cost Of Goods Sold -260000.0000 USD 4 0001654954-25-003717
0001654954-25-003717 20221231 Allowance For Doubtful Accounts Receivable 147000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20231231 Assets 4966000.0000 USD 0 us-gaap/2024 Income Tax Authority Name= Germanys;
0001654954-25-003717 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 12341000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 10326000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20231231 Common Stock Shares Authorized 30000000.0000 shares 0 us-gaap/2024
0001654954-25-003717 20241231 Common Stock Shares Authorized 30000000.0000 shares 0 us-gaap/2024
0001654954-25-003717 20241231 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents -321000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Foreign Currency Transaction Gain Loss Before Tax 58000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Gross Profit 11606000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Income Taxes Paid Net 459000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Increase Decrease In Accounts Receivable 719000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Net Income Loss 0.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-003717 20241231 Net Income Loss 0.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-003717 20241231 Nonoperating Income Expense 331000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Operating Income Loss 638000.0000 USD 4 us-gaap/2024 Geographical= Europes;
0001654954-25-003717 20241231 Operating Lease Liability 2160000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20241231 Other Comprehensive Income Loss Net Of Tax 0.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-003717 20241231 Other Long Term Notes Payable 112000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20231231 Research And Development Expense 6524000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Retained Earnings Accumulated Deficit -5738000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20231231 Revenues 8876000.0000 USD 4 us-gaap/2024 Geographical= Asia And Others;
0001654954-25-003717 20231231 Revenues 9469000.0000 USD 4 us-gaap/2024 Geographical= Europes;
0001654954-25-003717 20241231 Revenues 7250000.0000 USD 4 us-gaap/2024 Product Or Service= Adapter Sales;
0001654954-25-003717 20241231 Revenues 3534000.0000 USD 4 us-gaap/2024 Product Or Service= Software And Maintenance Sales;
0001654954-25-003717 20241231 Shares Issued 9236040.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-003717 20221231 Stockholders Equity -3131000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-003717 20231231 Stockholders Equity -2645000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-003717 20231231 Stock Issued During Period Value Employee Stock Purchase Plan 0.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-003717 20241231 Weighted Average Number Of Diluted Shares Outstanding 9150000.0000 shares 4 us-gaap/2024
0001654954-25-005511 20250331 Allowance For Doubtful Accounts Receivable 22000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20250331 Assets 24513000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20241231 Common Stock Value 23475000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20240331 Depreciation And Amortization 202000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20240331 Earnings Per Share Diluted -0.0900 USD 1 us-gaap/2024
0001654954-25-005511 20250331 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 104000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20240331 Gross Profit 3220000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20240331 Increase Decrease In Accounts Receivable -885000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20241231 Inventory Net 6212000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20240331 Issuance Of Stock Through Espp Amount 7000.0000 USD 1 0001654954-25-005511 Equity Components= Common Stock;
0001654954-25-005511 20240331 Issuance Of Stock Through Espp Amount 0.0000 USD 1 0001654954-25-005511 Equity Components= Retained Earnings;
0001654954-25-005511 20240331 Net Cash Provided By Used In Investing Activities -139000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20250331 Net Cash Provided By Used In Operating Activities 109000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20240331 Operating Expenses 4080000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20240331 Operating Income Loss -860000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20241231 Other Accrued Liabilities Current 1161000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20240331 Other Comprehensive Income Loss Net Of Tax 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-005511 20240331 Payments To Acquire Property Plant And Equipment 139000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20241231 Preferred Stock Shares Authorized 5000000.0000 shares 0 us-gaap/2024
0001654954-25-005511 20241231 Preferred Stock Value 0.0000 USD 0 us-gaap/2024
0001654954-25-005511 20240331 Revenues 3366000.0000 USD 1 us-gaap/2024 Product Or Service= Equipment Sales;
0001654954-25-005511 20250331 Revenues 6176000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20250331 Selling General And Administrative Expense 2050000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20240331 Weighted Average Number Of Diluted Shares Outstanding 9023000.0000 shares 1 us-gaap/2024
0001654954-25-005511 20240331 Weighted Average Number Of Shares Outstanding Basic 9023000.0000 shares 1 us-gaap/2024
0001654954-25-005511 20241231 Accounts Payable Current 820000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20241231 Accrued Income Taxes Current 39000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 281000.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-005511 20241231 Allowance For Doubtful Accounts Receivable 22000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 12341000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 10326000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20250331 Commitments And Contingencies 0.0000 USD 0 us-gaap/2024
0001654954-25-005511 20241231 Common Stock Shares Authorized 30000000.0000 shares 0 us-gaap/2024
0001654954-25-005511 20250331 Common Stock Shares Issued 9239731.0000 shares 0 us-gaap/2024
0001654954-25-005511 20250331 Earnings Per Share Diluted -0.0400 USD 1 us-gaap/2024
0001654954-25-005511 20250331 Gross Profit 3188000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20250331 Increase Decrease In Accounts Payable And Accrued Liabilities -12000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20250331 Increase Decrease In Accounts Receivable -132000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20240331 Increase Decrease In Deferred Revenue 279000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20250331 Increase Decrease In Other Current Assets 182000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20250331 Inventory Net 5820000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20240331 Issuance Of Stock Through Espp Shares 2381.0000 shares 1 0001654954-25-005511 Equity Components= Common Stock;
0001654954-25-005511 20250331 Net Cash Provided By Used In Investing Activities -56000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20250331 Net Income Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-005511 20250331 Other Assets Current 845000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20250331 Other Assets Noncurrent 2577000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20250331 Payments To Acquire Property Plant And Equipment 56000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20250331 Preferred Stock Value 0.0000 USD 0 us-gaap/2024
0001654954-25-005511 20241231 Retained Earnings Accumulated Deficit -5738000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20250331 Retained Earnings Accumulated Deficit -6120000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20240331 Revenues 887000.0000 USD 1 us-gaap/2024 Product Or Service= Software And Maintenance Sales;
0001654954-25-005511 20240331 Shares Issued 9024959.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-005511 20240331 Stock Awards Issued Net Of Tax Withholding Amount 0.0000 USD 1 0001654954-25-005511 Equity Components= Retained Earnings;
0001654954-25-005511 20240331 Stock Awards Issued Net Of Tax Withholding Shares 1759.0000 shares 1 0001654954-25-005511 Equity Components= Common Stock;
0001654954-25-003717 20231231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 0.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-003717 20241231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 0.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-003717 20231231 Allowance For Doubtful Accounts Receivable 72000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20241231 Assets 14292000.0000 USD 0 us-gaap/2024 Income Tax Authority Name= U S A;
0001654954-25-003717 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect 877000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Common Stock Shares Outstanding 9236040.0000 shares 0 us-gaap/2024
0001654954-25-003717 20241231 Comprehensive Income Net Of Tax -3437000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Cost Of Goods And Services Sold 10163000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents -46000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Income Tax Expense Benefit 194000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Increase Decrease In Deposit Other Assets -637000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Liabilities Current 6188000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20231231 Net Cash Provided By Used In Investing Activities -1195000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Net Cash Provided By Used In Operating Activities 2428000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Net Income Loss 0.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-003717 20231231 Operating Income Loss 196000.0000 USD 4 us-gaap/2024 Geographical= Asia And Others;
0001654954-25-003717 20241231 Operating Income Loss -965000.0000 USD 4 us-gaap/2024 Geographical= Asia And Others;
0001654954-25-003717 20241231 Operating Income Loss -857000.0000 USD 4 us-gaap/2024 Geographical= Europes;
0001654954-25-003717 20231231 Preferred Stock Value 0.0000 USD 0 us-gaap/2024
0001654954-25-003717 20231231 Revenues 16343000.0000 USD 4 us-gaap/2024 Product Or Service= Equipment Sales;
0001654954-25-003717 20241231 Revenues 5453000.0000 USD 4 us-gaap/2024 Geographical= Americas;
0001654954-25-003717 20241231 Revenues 10079000.0000 USD 4 us-gaap/2024 Geographical= Asia And Others;
0001654954-25-003717 20241231 Revenues 10985000.0000 USD 4 us-gaap/2024 Product Or Service= Equipment Sales;
0001654954-25-003717 20241231 Selling General And Administrative Expense 8404000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Stock Awards Issued Net Of Tax Withholding Amount 0.0000 USD 4 0001654954-25-003717 Equity Components= Retained Earnings;
0001654954-25-003717 20241231 Stock Awards Issued Net Of Tax Withholding Amount -246000.0000 USD 4 0001654954-25-003717
0001654954-25-003717 20241231 Stock Awards Issued Net Of Tax Withholding Shares 210202.0000 shares 4 0001654954-25-003717 Equity Components= Common Stock;
0001654954-25-003717 20231231 Stockholders Equity 20319000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20231231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 0.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-003717 20241231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 0.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-003717 20231231 Assets 27401000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20241231 Assets 6117000.0000 USD 0 us-gaap/2024 Income Tax Authority Name= China;
0001654954-25-003717 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect -1694000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Common Stock Shares Issued 9020819.0000 shares 0 us-gaap/2024
0001654954-25-003717 20231231 Common Stock Value 22731000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20241231 Common Stock Value 23475000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20231231 Deferred Revenue Current 1362000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20231231 Income Taxes Paid Net 171000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Increase Decrease In Other Noncurrent Liabilities 1458000.0000 USD 4 us-gaap/2024
0001654954-25-005511 20250331 Common Stock Value 23652000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20250331 Comprehensive Income Net Of Tax -256000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20240331 Cost Of Goods And Services Sold 2879000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20240331 Earnings Per Share Basic -0.0900 USD 1 us-gaap/2024
0001654954-25-005511 20250331 Foreign Currency Transaction Gain Loss Before Tax -22000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20240331 Income Tax Expense Benefit 41000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20250331 Increase Decrease In Deposit Other Assets -248000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20250331 Increase Decrease In Other Noncurrent Liabilities -254000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20250331 Interest Income Other 38000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20250331 Issuance Of Stock Through Espp Shares 1932.0000 shares 1 0001654954-25-005511 Equity Components= Common Stock;
0001654954-25-005511 20240331 Net Income Loss -807000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20250331 Net Income Loss -382000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20240331 Nonoperating Income Expense 94000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20250331 Nonoperating Income Expense 16000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20250331 Operating Income Loss -377000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20241231 Operating Lease Liability 2160000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20250331 Other Accrued Liabilities Current 1205000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20241231 Other Assets Current 659000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20250331 Other Long Term Notes Payable 59000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20250331 Proceeds From Issuance Of Common Stock 2000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20240331 Research And Development Expense 1582000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20240331 Revenues 1846000.0000 USD 1 us-gaap/2024 Product Or Service= Adapter Sales;
0001654954-25-005511 20231231 Shares Issued 9020819.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-005511 20240331 Stock Awards Issued Net Of Tax Withholding Amount 0.0000 USD 1 0001654954-25-005511 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-005511 20250331 Stock Awards Issued Net Of Tax Withholding Amount 0.0000 USD 1 0001654954-25-005511 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-005511 20250331 Stockholders Equity 23652000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-003717 20231231 Net Cash Provided By Used In Financing Activities -356000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Net Income Loss -3093000.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-003717 20231231 Operating Income Loss 448000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Other Assets Current 690000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20241231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax -344000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Preferred Stock Shares Authorized 5000000.0000 shares 0 us-gaap/2024
0001654954-25-003717 20241231 Preferred Stock Value 0.0000 USD 0 us-gaap/2024
0001654954-25-003717 20231231 Revenues 28064000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Revenues 8154000.0000 USD 4 us-gaap/2024 Product Or Service= Adapter Sales;
0001654954-25-003717 20221231 Shares Issued 8816381.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-003717 20231231 Stock Awards Issued Net Of Tax Withholding Shares 201172.0000 shares 4 0001654954-25-003717 Equity Components= Common Stock;
0001654954-25-003717 20231231 Stock Issued During Period Value Employee Stock Purchase Plan 14000.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-003717 20241231 Stock Issued During Period Value Employee Stock Purchase Plan 14000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Accounts Payable Current 820000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20231231 Accumulated Other Comprehensive Income Loss Net Of Tax 233000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20231231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 1190000.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-003717 20241231 Allowance For Doubtful Accounts Receivable 22000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20231231 Comprehensive Income Net Of Tax 376000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Depreciation And Amortization 608000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Depreciation And Amortization 564000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Earnings Per Share Basic 0.0500 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Earnings Per Share Diluted -0.3400 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Gross Profit 16186000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Increase Decrease In Accounts Receivable -1711000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Liabilities And Stockholders Equity 24970000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20231231 Net Income Loss 486000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Operating Income Loss -386000.0000 USD 4 us-gaap/2024 Geographical= Americas;
0001654954-25-003717 20231231 Other Accrued Liabilities Current 1438000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20231231 Other Assets Noncurrent 1429000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20231231 Other Comprehensive Income Loss Net Of Tax -110000.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-003717 20231231 Other Long Term Notes Payable 192000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20231231 Payments To Acquire Property Plant And Equipment 1195000.0000 USD 4 us-gaap/2024
0001654954-25-005511 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 174000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 11999000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect -173000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20250331 Increase Decrease In Deferred Revenue -160000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20240331 Increase Decrease In Other Current Assets 49000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20240331 Issuance Of Stock Through Espp Amount 7000.0000 USD 1 0001654954-25-005511
0001654954-25-005511 20240331 Issuance Of Stock Through Espp Amount 0.0000 USD 1 0001654954-25-005511 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-005511 20250331 Issuance Of Stock Through Espp Amount 0.0000 USD 1 0001654954-25-005511 Equity Components= Retained Earnings;
0001654954-25-005511 20250331 Liabilities And Stockholders Equity 24513000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20250331 Other Comprehensive Income Loss Net Of Tax 126000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20250331 Other Comprehensive Income Loss Net Of Tax 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-005511 20241231 Preferred Stock Shares Authorized 200000.0000 shares 0 us-gaap/2024 Class Of Stock= Series A Preferred Stock;
0001654954-25-005511 20240331 Revenues 6099000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20240331 Selling General And Administrative Expense 2498000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20240331 Share Based Compensation 281000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20240331 Stock Awards Issued Net Of Tax Withholding Amount 0.0000 USD 1 0001654954-25-005511 Equity Components= Common Stock;
0001654954-25-005511 20250331 Stock Awards Issued Net Of Tax Withholding Amount -3000.0000 USD 1 0001654954-25-005511
0001654954-25-005511 20231231 Stockholders Equity 20319000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20231231 Stockholders Equity 22731000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-005511 20240331 Stockholders Equity 19632000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20250331 Weighted Average Number Of Shares Outstanding Basic 9238000.0000 shares 1 us-gaap/2024
0001654954-25-003717 20231231 Retained Earnings Accumulated Deficit -2645000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20231231 Revenues 3567000.0000 USD 4 us-gaap/2024 Product Or Service= Software And Maintenance Sales;
0001654954-25-003717 20241231 Share Based Compensation 977000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Stock Awards Issued Net Of Tax Withholding Amount -370000.0000 USD 4 0001654954-25-003717 Equity Components= Common Stock;
0001654954-25-003717 20221231 Stockholders Equity 343000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-003717 20221231 Stockholders Equity 21897000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-003717 20231231 Stock Issued During Period Value Employee Stock Purchase Plan 0.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-003717 20241231 Operating Expenses 14644000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Accrued Income Taxes Current 39000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20241231 Assets 24970000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20241231 Assets 4561000.0000 USD 0 us-gaap/2024 Income Tax Authority Name= Germanys;
0001654954-25-003717 20241231 Common Stock Shares Issued 9236040.0000 shares 0 us-gaap/2024
0001654954-25-003717 20241231 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -2707000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Increase Decrease In Accounts Payable And Accrued Liabilities -1263000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Increase Decrease In Deferred Revenue 122000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Increase Decrease In Deposit Other Assets 1402000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Increase Decrease In Inventories 358000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Increase Decrease In Other Current Assets -29000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Interest Income Other 190000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Inventory Net 6212000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20241231 Net Cash Provided By Used In Financing Activities -232000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20231231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax -110000.0000 USD 4 us-gaap/2024
0001654954-25-003717 20241231 Property Plant And Equipment Net 1001000.0000 USD 0 us-gaap/2024
0001654954-25-003717 20231231 Revenues 9719000.0000 USD 4 us-gaap/2024 Geographical= Americas;
0001654954-25-003717 20231231 Stock Awards Issued Net Of Tax Withholding Amount -370000.0000 USD 4 0001654954-25-003717
0001654954-25-003717 20231231 Stockholders Equity 233000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-003717 20241231 Stock Issued During Period Shares Employee Stock Purchase Plans 5019.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-005511 20241231 Accrued Compensation 1517000.0000 USD 0 0001654954-25-005511
0001654954-25-005511 20250331 Accrued Compensation 955000.0000 USD 0 0001654954-25-005511
0001654954-25-005511 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-005511 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 174000.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-005511 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 0.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-005511 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect 55000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20241231 Commitments And Contingencies 0.0000 USD 0 us-gaap/2024
0001654954-25-005511 20241231 Common Stock Shares Issued 9236040.0000 shares 0 us-gaap/2024
0001654954-25-005511 20241231 Common Stock Shares Outstanding 9236040.0000 shares 0 us-gaap/2024
0001654954-25-005511 20250331 Common Stock Shares Outstanding 9239731.0000 shares 0 us-gaap/2024
0001654954-25-005511 20240331 Comprehensive Income Net Of Tax -975000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20250331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -361000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20240331 Increase Decrease In Inventories 496000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20240331 Increase Decrease In Other Noncurrent Liabilities -140000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20250331 Issuance Of Stock Through Espp Amount 0.0000 USD 1 0001654954-25-005511 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-005511 20241231 Liabilities Current 5072000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20240331 Net Income Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001654954-25-005511 20240331 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax -168000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20240331 Other Comprehensive Income Loss Net Of Tax 0.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001654954-25-005511 20241231 Other Long Term Notes Payable 112000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20240331 Proceeds From Issuance Of Common Stock 7000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20241231 Property Plant And Equipment Net 1001000.0000 USD 0 us-gaap/2024
0001654954-25-005511 20250331 Research And Development Expense 1515000.0000 USD 1 us-gaap/2024
0001654954-25-005511 20241231 Shares Issued 9236040.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-005511 20250331 Shares Issued 9239731.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001654954-25-005511 20240331 Stock Awards Issued Net Of Tax Withholding Amount 0.0000 USD 1 0001654954-25-005511
0001654954-25-005511 20231231 Stockholders Equity 233000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Increase Decrease In Accounts Receivable us-gaap/2024 0 0 monetary D C Increase (Decrease) in Accounts Receivable The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
Assets Current us-gaap/2024 0 0 monetary I D Assets, Current Amount of asset recognized for present right to economic benefit, classified as current.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 0 0 monetary I D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Increase Decrease In Deposit Other Assets us-gaap/2024 0 0 monetary D C Increase (Decrease) in Deposit Assets The increase (decrease) during the reporting period in moneys or securities given as security including, but not limited to, contract, escrow, or earnest money deposits, retainage (if applicable), deposits with clearing organizations and others, collateral, or margin deposits.
Stock Awards Issued Net Of Tax Withholding Amount 0001654954-25-005511 1 0 monetary D C Stock awards issued, net of tax withholding, amount
Depreciation And Amortization us-gaap/2024 0 0 monetary D D Depreciation, Depletion and Amortization, Nonproduction The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.
Payments To Acquire Property Plant And Equipment us-gaap/2024 0 0 monetary D C Payments to Acquire Property, Plant, and Equipment The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Comprehensive Income Net Of Tax us-gaap/2024 0 0 monetary D C Comprehensive Income (Loss), Net of Tax, Attributable to Parent Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Deferred Revenue Current us-gaap/2024 0 0 monetary I C Deferred Revenue, Current Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 0 0 monetary D C Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Liabilities And Stockholders Equity us-gaap/2024 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Retained Earnings Accumulated Deficit us-gaap/2024 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Income Tax Expense Benefit us-gaap/2024 0 0 monetary D D Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Accounts Receivable Net Current us-gaap/2024 0 0 monetary I D Accounts Receivable, after Allowance for Credit Loss, Current Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Common Stock Shares Outstanding us-gaap/2024 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Stockholders Equity us-gaap/2024 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Net Income Loss us-gaap/2024 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Stock Issued During Period Value Employee Stock Purchase Plan us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Employee Stock Purchase Plan Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.
Accrued Compensation 0001654954-25-005511 1 0 monetary I C Accrued compensation
Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 0 0 monetary I C Accumulated Other Comprehensive Income (Loss), Net of Tax Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.
Allowance For Doubtful Accounts Receivable us-gaap/2024 0 0 monetary I C Accounts Receivable, Allowance for Credit Loss Amount of allowance for credit loss on accounts receivable.
Assets us-gaap/2024 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Common Stock Shares Issued us-gaap/2024 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Cost Of Goods And Services Sold us-gaap/2024 0 0 monetary D D Cost of Goods and Services Sold The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.
Earnings Per Share Diluted us-gaap/2024 0 0 perShare D Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 0 0 monetary D D Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Gross Profit us-gaap/2024 0 0 monetary D C Gross Profit Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
Other Assets Noncurrent us-gaap/2024 0 0 monetary I D Other Assets, Noncurrent Amount of noncurrent assets classified as other.
Shares Issued us-gaap/2024 0 0 shares I Shares, Issued Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.
Liabilities Current us-gaap/2024 0 0 monetary I C Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Issuance Of Stock Through Espp Amount 0001654954-25-005511 1 0 monetary D C Issuance of stock through: ESPP, amount
Operating Lease Liability us-gaap/2024 0 0 monetary I C Operating Lease, Liability Present value of lessee's discounted obligation for lease payments from operating lease.
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 0 0 monetary D C Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.
Selling General And Administrative Expense us-gaap/2024 0 0 monetary D D Selling, General and Administrative Expense The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.
Share Based Compensation us-gaap/2024 0 0 monetary D D Share-Based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement.
Stock Awards Issued Net Of Tax Withholding Shares 0001654954-25-005511 1 0 shares D Stock awards issued, net of tax withholding, shares
Nonoperating Income Expense us-gaap/2024 0 0 monetary D C Nonoperating Income (Expense) The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Foreign Currency Transaction Gain Loss Before Tax us-gaap/2024 0 0 monetary D C Gain (Loss), Foreign Currency Transaction, before Tax Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction.
Income Taxes Paid Net us-gaap/2024 0 0 monetary D C Income Taxes Paid, Net Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.
Increase Decrease In Inventories us-gaap/2024 0 0 monetary D C Increase (Decrease) in Inventories The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.
Other Comprehensive Income Loss Net Of Tax us-gaap/2024 0 0 monetary D C Other Comprehensive Income (Loss), Net of Tax Amount after tax and reclassification adjustments of other comprehensive income (loss).
Preferred Stock Value us-gaap/2024 0 0 monetary I C Preferred Stock, Value, Issued Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
Stock Awards Issued Net Of Tax Withholding Amount 0001654954-25-003717 1 0 monetary D C Stock awards issued, net of tax withholding, amount
Net Cash Provided By Used In Operating Activities us-gaap/2024 0 0 monetary D Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Accrued Income Taxes Current us-gaap/2024 0 0 monetary I C Accrued Income Taxes, Current Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.
Operating Expenses us-gaap/2024 0 0 monetary D D Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
Operating Income Loss us-gaap/2024 0 0 monetary D C Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues.
Other Assets Current us-gaap/2024 0 0 monetary I D Other Assets, Current Amount of current assets classified as other.
Accrued Compensation 0001654954-25-003717 1 0 monetary I C Accrued compensation
Common Stock Value us-gaap/2024 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Adjustments To Equipment Transferred To Cost Of Goods Sold 0001654954-25-005511 1 0 monetary D C [Equipment transferred to cost of goods sold]
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect us-gaap/2024 0 0 monetary D D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Increase Decrease In Other Current Assets us-gaap/2024 0 0 monetary D C Increase (Decrease) in Other Current Assets Amount of increase (decrease) in current assets classified as other.
Inventory Net us-gaap/2024 0 0 monetary I D Inventory, Net Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Research And Development Expense us-gaap/2024 0 0 monetary D D Research and Development Expense Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.
Revenues us-gaap/2024 0 0 monetary D C Revenues Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Adjustments To Equipment Transferred To Cost Of Goods Sold 0001654954-25-003717 1 0 monetary D C [Equipment transferred to cost of goods sold]
Accounts Payable Current us-gaap/2024 0 0 monetary I C Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Commitments And Contingencies us-gaap/2024 0 0 monetary I C Commitments and Contingencies Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
Common Stock Shares Authorized us-gaap/2024 0 0 shares I Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Interest Income Other us-gaap/2024 0 0 monetary D C Interest Income, Other Amount of interest income earned from interest bearing assets classified as other.
Net Cash Provided By Used In Financing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Other Accrued Liabilities Current us-gaap/2024 0 0 monetary I C Other Accrued Liabilities, Current Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.
Other Long Term Notes Payable us-gaap/2024 0 0 monetary I C Other Notes Payable, Noncurrent Amount of long-term notes classified as other, payable after one year or the normal operating cycle, if longer.
Increase Decrease In Deferred Revenue us-gaap/2024 0 0 monetary D D Increase (Decrease) in Deferred Revenue Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.
Stock Awards Issued Net Of Tax Withholding Shares 0001654954-25-003717 1 0 shares D Stock awards issued, net of tax withholding, shares
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 0 0 monetary D C APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.
Earnings Per Share Basic us-gaap/2024 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Increase Decrease In Accounts Payable And Accrued Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Accounts Payable and Accrued Liabilities The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.
Net Cash Provided By Used In Investing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Preferred Stock Shares Authorized us-gaap/2024 0 0 shares I Preferred Stock, Shares Authorized The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Proceeds From Issuance Of Common Stock us-gaap/2024 0 0 monetary D D Proceeds from Issuance of Common Stock The cash inflow from the additional capital contribution to the entity.
Stock Issued During Period Shares Employee Stock Purchase Plans us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, Employee Stock Purchase Plans Number of shares issued during the period as a result of an employee stock purchase plan.
Increase Decrease In Other Noncurrent Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Other Noncurrent Liabilities Amount of increase (decrease) in noncurrent operating liabilities classified as other.
Property Plant And Equipment Net us-gaap/2024 0 0 monetary I D Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Issuance Of Stock Through Espp Shares 0001654954-25-005511 1 0 shares D Issuance of stock through: ESPP, shares

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0001654954-25-003717 5 1 CI 0 H Net Income Loss us-gaap/2024 Net Income (loss) 0
0001654954-25-003717 4 18 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 Weighted-average diluted shares 0
0001654954-25-003717 2 2 BS 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents 0
0001654954-25-003717 2 3 BS 0 H Accounts Receivable Net Current us-gaap/2024 Trade accounts receivable, net of allowance for credit losses of $22 and $72, respectively 0
0001654954-25-003717 2 4 BS 0 H Inventory Net us-gaap/2024 Inventories 0
0001654954-25-003717 2 5 BS 0 H Other Assets Current us-gaap/2024 Other current assets 0
0001654954-25-003717 2 6 BS 0 H Assets Current us-gaap/2024 TOTAL CURRENT ASSETS 0
0001654954-25-003717 2 7 BS 0 H Property Plant And Equipment Net us-gaap/2024 Property, plant and equipment - net 0
0001654954-25-003717 2 8 BS 0 H Other Assets Noncurrent us-gaap/2024 Other assets 0
0001654954-25-003717 2 9 BS 0 H Assets us-gaap/2024 TOTAL ASSETS 0
0001654954-25-003717 2 11 BS 0 H Accounts Payable Current us-gaap/2024 Accounts payable 0
0001654954-25-003717 2 12 BS 0 H Accrued Compensation 0001654954-25-003717 Accrued compensation 0
0001654954-25-003717 2 13 BS 0 H Deferred Revenue Current us-gaap/2024 Deferred revenue 0
0001654954-25-003717 2 14 BS 0 H Other Accrued Liabilities Current us-gaap/2024 Other accrued liabilities 0
0001654954-25-003717 2 15 BS 0 H Accrued Income Taxes Current us-gaap/2024 Income taxes payable 0
0001654954-25-003717 2 16 BS 0 H Liabilities Current us-gaap/2024 TOTAL CURRENT LIABILITIES 0
0001654954-25-003717 2 17 BS 0 H Operating Lease Liability us-gaap/2024 Operating lease liabilities 0
0001654954-25-003717 2 18 BS 0 H Other Long Term Notes Payable us-gaap/2024 Long-term other payables 0
0001654954-25-003717 2 20 BS 0 H Preferred Stock Value us-gaap/2024 Preferred stock - Authorized, 5,000,000 shares, including 200,000 shares of Series A Junior Participating Issued and outstanding, none 0
0001654954-25-003717 2 21 BS 0 H Common Stock Value us-gaap/2024 Common stock, at stated value - Authorized, 30,000,000 shares Issued and outstanding, 9,236,040 shares as of December 31, 2024 and 9,020,819 shares as of December 31, 2023 0
0001654954-25-003717 2 22 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Accumulated earnings (deficit) 0
0001654954-25-003717 2 23 BS 0 H Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Accumulated other comprehensive income 0
0001654954-25-003717 2 24 BS 0 H Stockholders Equity us-gaap/2024 TOTAL STOCKHOLDERS' EQUITY 0
0001654954-25-003717 2 25 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 0
0001654954-25-003717 3 1 BS 1 H Allowance For Doubtful Accounts Receivable us-gaap/2024 Allowance for credit losses of trade accounts receivable 0
0001654954-25-003717 3 2 BS 1 H Preferred Stock Shares Authorized us-gaap/2024 Preferred Stock, Authorized Shares 0
0001654954-25-003717 3 3 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common Stock, Authorized Shares 0
0001654954-25-003717 3 4 BS 1 H Common Stock Shares Issued us-gaap/2024 Common Stock, Issued Shares 0
0001654954-25-003717 3 5 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Common Stock, Outstanding Shares 0
0001654954-25-003717 4 1 IS 0 H Revenues us-gaap/2024 Net sales 0
0001654954-25-003717 4 2 IS 0 H Cost Of Goods And Services Sold us-gaap/2024 Cost of goods sold 0
0001654954-25-003717 4 3 IS 0 H Gross Profit us-gaap/2024 Gross margin 0
0001654954-25-003717 4 5 IS 0 H Research And Development Expense us-gaap/2024 Research and development 0
0001654954-25-003717 4 6 IS 0 H Selling General And Administrative Expense us-gaap/2024 Selling, general and administrative 0
0001654954-25-003717 4 7 IS 0 H Operating Expenses us-gaap/2024 Total operating expenses 0
0001654954-25-003717 4 8 IS 0 H Operating Income Loss us-gaap/2024 Operating income (loss) 0
0001654954-25-003717 4 9 IS 0 H Interest Income Other us-gaap/2024 Interest income 0
0001654954-25-003717 4 10 IS 0 H Foreign Currency Transaction Gain Loss Before Tax us-gaap/2024 Foreign currency transaction gain (loss) 0
0001654954-25-003717 4 11 IS 0 H Nonoperating Income Expense us-gaap/2024 Total non-operating income (loss) 0
0001654954-25-003717 4 12 IS 0 H Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 Income (loss) before income taxes 0
0001654954-25-003717 4 13 IS 0 H Income Tax Expense Benefit us-gaap/2024 Income tax (expense) benefit 1
0001654954-25-003717 4 14 IS 0 H Net Income Loss us-gaap/2024 Net income (loss) 0
0001654954-25-003717 4 15 IS 0 H Earnings Per Share Basic us-gaap/2024 Basic earnings (loss) per share 0
0001654954-25-003717 4 16 IS 0 H Earnings Per Share Diluted us-gaap/2024 Diluted earnings (loss) per share 0
0001654954-25-003717 4 17 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 Weighted-average basic shares 0
0001654954-25-003717 5 3 CI 0 H Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 Foreign currency translation gain (loss) 0
0001654954-25-003717 5 4 CI 0 H Comprehensive Income Net Of Tax us-gaap/2024 Comprehensive income (loss) 0
0001654954-25-003717 6 8 EQ 0 H Shares Issued us-gaap/2024 Balance, shares 0
0001654954-25-003717 6 9 EQ 0 H Stockholders Equity us-gaap/2024 Balance, amount 0
0001654954-25-003717 6 10 EQ 0 H Stock Awards Issued Net Of Tax Withholding Shares 0001654954-25-003717 Stock awards issued, net of tax withholding, shares 0
0001654954-25-003717 6 11 EQ 0 H Stock Awards Issued Net Of Tax Withholding Amount 0001654954-25-003717 Stock awards issued, net of tax withholding, amount 0
0001654954-25-003717 6 12 EQ 0 H Stock Issued During Period Shares Employee Stock Purchase Plans us-gaap/2024 Employee Stock Purchase Plan, shares 0
0001654954-25-003717 6 13 EQ 0 H Stock Issued During Period Value Employee Stock Purchase Plan us-gaap/2024 Employee Stock Purchase Plan, amount 0
0001654954-25-003717 6 14 EQ 0 H Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 Share-based compensation 0
0001654954-25-005511 2 2 BS 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents 0
0001654954-25-005511 2 3 BS 0 H Accounts Receivable Net Current us-gaap/2024 Trade accounts receivable, net of allowance for credit losses of $22 and $22, respectively 0
0001654954-25-005511 2 4 BS 0 H Inventory Net us-gaap/2024 Inventories 0
0001654954-25-005511 2 5 BS 0 H Other Assets Current us-gaap/2024 Other current assets 0
0001654954-25-005511 2 6 BS 0 H Assets Current us-gaap/2024 TOTAL CURRENT ASSETS 0
0001654954-25-005511 2 7 BS 0 H Property Plant And Equipment Net us-gaap/2024 Property, plant and equipment - net 0
0001654954-25-005511 2 8 BS 0 H Other Assets Noncurrent us-gaap/2024 Other assets 0
0001654954-25-005511 2 9 BS 0 H Assets us-gaap/2024 TOTAL ASSETS 0
0001654954-25-005511 2 11 BS 0 H Accounts Payable Current us-gaap/2024 Accounts payable 0
0001654954-25-005511 2 12 BS 0 H Accrued Compensation 0001654954-25-005511 Accrued compensation 0
0001654954-25-005511 2 13 BS 0 H Deferred Revenue Current us-gaap/2024 Deferred revenue 0
0001654954-25-005511 2 14 BS 0 H Other Accrued Liabilities Current us-gaap/2024 Other accrued liabilities 0
0001654954-25-005511 2 15 BS 0 H Accrued Income Taxes Current us-gaap/2024 Income taxes payable 0
0001654954-25-005511 2 16 BS 0 H Liabilities Current us-gaap/2024 TOTAL CURRENT LIABILITIES 0
0001654954-25-005511 2 17 BS 0 H Operating Lease Liability us-gaap/2024 Operating lease liabilities 0
0001654954-25-005511 2 18 BS 0 H Other Long Term Notes Payable us-gaap/2024 Long-term other payables 0
0001654954-25-005511 2 19 BS 0 H Commitments And Contingencies us-gaap/2024 COMMITMENTS 0
0001654954-25-005511 2 21 BS 0 H Preferred Stock Value us-gaap/2024 Preferred stock - Authorized, 5,000,000 shares, including 200,000 shares of Series A Junior Participating Issued and outstanding, none 0
0001654954-25-005511 2 22 BS 0 H Common Stock Value us-gaap/2024 Common stock, at stated value - Authorized, 30,000,000 shares Issued and outstanding, 9,239,731 shares as of March 31, 2025 and 9,236,040 shares as of December 31, 2024 0
0001654954-25-005511 2 23 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Accumulated earnings (deficit) 0
0001654954-25-005511 2 24 BS 0 H Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Accumulated other comprehensive income 0
0001654954-25-005511 2 25 BS 0 H Stockholders Equity us-gaap/2024 TOTAL STOCKHOLDERS' EQUITY 0
0001654954-25-005511 2 26 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 0
0001654954-25-005511 3 1 BS 1 H Allowance For Doubtful Accounts Receivable us-gaap/2024 Allowance for credit losses of trade accounts receivable 0
0001654954-25-005511 3 2 BS 1 H Preferred Stock Shares Authorized us-gaap/2024 Preferred Stock, Authorized Shares 0
0001654954-25-005511 3 3 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common Stock, Authorized Shares 0
0001654954-25-005511 3 4 BS 1 H Common Stock Shares Issued us-gaap/2024 Common Stock, Issued Shares 0
0001654954-25-005511 3 5 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Common Stock, Outstanding Shares 0
0001654954-25-005511 4 1 IS 0 H Revenues us-gaap/2024 Net sales 0
0001654954-25-005511 4 2 IS 0 H Cost Of Goods And Services Sold us-gaap/2024 Cost of goods sold 0
0001654954-25-005511 4 3 IS 0 H Gross Profit us-gaap/2024 Gross margin 0
0001654954-25-005511 4 5 IS 0 H Research And Development Expense us-gaap/2024 Research and development 0
0001654954-25-005511 4 6 IS 0 H Selling General And Administrative Expense us-gaap/2024 Selling, general and administrative 0
0001654954-25-005511 4 7 IS 0 H Operating Expenses us-gaap/2024 Total operating expenses 0
0001654954-25-005511 4 8 IS 0 H Operating Income Loss us-gaap/2024 Operating income (loss) 0
0001654954-25-005511 4 9 IS 0 H Interest Income Other us-gaap/2024 Interest income 0
0001654954-25-005511 4 10 IS 0 H Foreign Currency Transaction Gain Loss Before Tax us-gaap/2024 Foreign currency transaction gain (loss) 0
0001654954-25-005511 4 11 IS 0 H Nonoperating Income Expense us-gaap/2024 Total non-operating income (loss) 0
0001654954-25-005511 4 12 IS 0 H Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 Income (loss) before income taxes 0
0001654954-25-005511 4 13 IS 0 H Income Tax Expense Benefit us-gaap/2024 Income tax (expense) benefit 1
0001654954-25-005511 4 14 IS 0 H Net Income Loss us-gaap/2024 Net income (loss) 0
0001654954-25-005511 4 15 IS 0 H Earnings Per Share Basic us-gaap/2024 Basic earnings (loss) per share 0
0001654954-25-005511 4 16 IS 0 H Earnings Per Share Diluted us-gaap/2024 Diluted earnings (loss) per share 0
0001654954-25-005511 4 17 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 Weighted-average basic shares 0
0001654954-25-005511 4 18 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 Weighted-average diluted shares 0
0001654954-25-005511 5 1 CI 0 H Net Income Loss us-gaap/2024 Net Income (loss) 0
0001654954-25-005511 5 3 CI 0 H Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 Foreign currency translation gain (loss) 0
0001654954-25-005511 5 4 CI 0 H Comprehensive Income Net Of Tax us-gaap/2024 Comprehensive income (loss) 0
0001654954-25-005511 6 8 EQ 0 H Shares Issued us-gaap/2024 Balance, shares 0
0001654954-25-005511 6 9 EQ 0 H Stockholders Equity us-gaap/2024 Balance, amount 0
0001654954-25-005511 6 10 EQ 0 H Stock Awards Issued Net Of Tax Withholding Shares 0001654954-25-005511 Stock awards issued, net of tax withholding, shares 0
0001654954-25-005511 6 11 EQ 0 H Stock Awards Issued Net Of Tax Withholding Amount 0001654954-25-005511 Stock awards issued, net of tax withholding, amount 0
0001654954-25-005511 6 12 EQ 0 H Issuance Of Stock Through Espp Shares 0001654954-25-005511 Issuance of stock through: ESPP, shares 0
0001654954-25-005511 6 13 EQ 0 H Issuance Of Stock Through Espp Amount 0001654954-25-005511 Issuance of stock through: ESPP, amount 0
0001654954-25-005511 6 14 EQ 0 H Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 Share-based compensation 0
0001654954-25-005511 6 15 EQ 0 H Net Income Loss us-gaap/2024 Net income (loss) 0
0001654954-25-005511 6 16 EQ 0 H Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Other comprehensive income (loss) 0
0001654954-25-005511 6 17 EQ 0 H Shares Issued us-gaap/2024 Balance, shares 0
0001654954-25-005511 6 18 EQ 0 H Stockholders Equity us-gaap/2024 Balance, amount 0
0001654954-25-005511 7 1 CF 0 H Net Income Loss us-gaap/2024 Net income (loss) 0
0001654954-25-005511 7 3 CF 0 H Depreciation And Amortization us-gaap/2024 Depreciation and amortization 0
0001654954-25-005511 7 4 CF 0 H Adjustments To Equipment Transferred To Cost Of Goods Sold 0001654954-25-005511 Equipment transferred to cost of goods sold 1
0001654954-25-005511 7 5 CF 0 H Share Based Compensation us-gaap/2024 Share-based compensation 0
0001654954-25-005511 7 7 CF 0 H Increase Decrease In Accounts Receivable us-gaap/2024 Trade accounts receivable 1
0001654954-25-005511 7 8 CF 0 H Increase Decrease In Inventories us-gaap/2024 Inventories 1
0001654954-25-005511 7 9 CF 0 H Increase Decrease In Other Current Assets us-gaap/2024 Other current assets 1
0001654954-25-005511 7 10 CF 0 H Increase Decrease In Accounts Payable And Accrued Liabilities us-gaap/2024 Accounts payable and accrued liabilities 0
0001654954-25-005511 7 11 CF 0 H Increase Decrease In Deferred Revenue us-gaap/2024 Deferred revenue 0
0001654954-25-005511 7 12 CF 0 H Increase Decrease In Other Noncurrent Liabilities us-gaap/2024 Other long-term liabilities 0
0001654954-25-005511 7 13 CF 0 H Increase Decrease In Deposit Other Assets us-gaap/2024 Deposits and other long-term assets 1
0001654954-25-005511 7 14 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net cash provided by (used in) operating activities 0
0001654954-25-005511 7 16 CF 0 H Payments To Acquire Property Plant And Equipment us-gaap/2024 Purchases of property, plant and equipment 1
0001654954-25-005511 7 17 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Cash provided by (used in) investing activities 0
0001654954-25-005511 7 19 CF 0 H Proceeds From Issuance Of Common Stock us-gaap/2024 Net proceeds from issuance of common stock, less payments for shares withheld to cover tax 0
0001654954-25-005511 7 20 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Cash provided by (used in) financing activities 0
0001654954-25-005511 7 21 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect us-gaap/2024 Increase (decrease) in cash and cash equivalents 0
0001654954-25-005511 7 22 CF 0 H Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Effects of exchange rate changes on cash 0
0001654954-25-005511 7 23 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents at beginning of period 0
0001654954-25-005511 7 24 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents at end of period 0
0001654954-25-005511 7 25 CF 0 H Income Taxes Paid Net us-gaap/2024 Income taxes 0
0001654954-25-003717 6 15 EQ 0 H Net Income Loss us-gaap/2024 Net income (loss) 0
0001654954-25-003717 6 16 EQ 0 H Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Other comprehensive income gain (loss) 0
0001654954-25-003717 6 17 EQ 0 H Shares Issued us-gaap/2024 Balance, shares 0
0001654954-25-003717 6 18 EQ 0 H Stockholders Equity us-gaap/2024 Balance, amount 0
0001654954-25-003717 7 1 CF 0 H Net Income Loss us-gaap/2024 Net income (loss) 0
0001654954-25-003717 7 2 CF 0 H Depreciation And Amortization us-gaap/2024 Depreciation and amortization 0
0001654954-25-003717 7 3 CF 0 H Adjustments To Equipment Transferred To Cost Of Goods Sold 0001654954-25-003717 Equipment transferred to cost of goods sold 1
0001654954-25-003717 7 4 CF 0 H Share Based Compensation us-gaap/2024 Share-based compensation 0
0001654954-25-003717 7 6 CF 0 H Increase Decrease In Accounts Receivable us-gaap/2024 Trade accounts receivable 1
0001654954-25-003717 7 7 CF 0 H Increase Decrease In Inventories us-gaap/2024 Inventories 1
0001654954-25-003717 7 8 CF 0 H Increase Decrease In Other Current Assets us-gaap/2024 Other current assets 1
0001654954-25-003717 7 9 CF 0 H Increase Decrease In Accounts Payable And Accrued Liabilities us-gaap/2024 Accounts payable and accrued liabilities 0
0001654954-25-003717 7 10 CF 0 H Increase Decrease In Deferred Revenue us-gaap/2024 Deferred revenue 0
0001654954-25-003717 7 11 CF 0 H Increase Decrease In Other Noncurrent Liabilities us-gaap/2024 Other long-term liabilities 0
0001654954-25-003717 7 12 CF 0 H Increase Decrease In Deposit Other Assets us-gaap/2024 Deposits and other long-term assets 1
0001654954-25-003717 7 13 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net cash provided by (used in) operating activities 0
0001654954-25-003717 7 15 CF 0 H Payments To Acquire Property Plant And Equipment us-gaap/2024 Purchases of property, plant and equipment 1
0001654954-25-003717 7 16 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Cash provided by (used in) investing activities 0
0001654954-25-003717 7 18 CF 0 H Proceeds From Issuance Of Common Stock us-gaap/2024 Net proceeds from issuance of common stock, less payments for shares withheld to cover tax 0
0001654954-25-003717 7 19 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Cash provided by (used in) financing activities 0
0001654954-25-003717 7 20 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect us-gaap/2024 Increase (decrease) in cash and cash equivalents 0
0001654954-25-003717 7 21 CF 0 H Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Effects of exchange rate changes on cash 0
0001654954-25-003717 7 22 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents at beginning of period 0
0001654954-25-003717 7 23 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents at end of period 0
0001654954-25-003717 7 24 CF 0 H Income Taxes Paid Net us-gaap/2024 Income taxes 0

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.